Pharma Mar, S.A
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer. The company also develops clinical-stage programs, including Aplidin, Zepsyre, PM184, and PM14. In addition, it develops and markets diagnostics kits; and produces and markets insecticides and air fresheners for household use and household products. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. Show More...
-
Website http://www.pharmamar.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 28.82 EUR
-
Last Updated 25-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR -0.03 0.02 -0.19 0.05 0.06 0.03 -0.11 -0.12 -0.03 -0.05 0.32 Dividends EUR Payout Ratio % * Shares Mil 221.0 222.0 221.0 221.0 221.0 221.0 221.0 221.0 221.0 221.0 222.0 Book Value Per Share * EUR 0.17 0.13 0.19 0.26 0.32 0.36 0.27 0.18 0.15 -0.02 0.37 Free Cash Flow Per Share * EUR -0.15 -0.09 0.02 -0.010 0.1 -0.04 -0.02 -0.1 -0.11 Return on Assets % -3.33 2.11 3.16 5.82 6.71 3.19 -11.12 -13.08 -3.21 -8.06 31.55 Financial Leverage (Average) 6.69 5.51 4.72 3.56 3.15 2.76 4.22 6.99 7.38 10.96 3.39 Return on Equity % -19.43 12.8 16.1 23.7 22.4 9.36 -37.27 -67.52 -22.95 -69.5 150.31 Return on Invested Capital % -3.95 4.9 6.1 10.57 12.2 6.4 -12.05 -16.73 -1.25 -8.0 54.66 Interest Coverage 1.17 2.55 3.14 3.26 2.09 -3.74 -3.46 -2.97 -4.57 Current Ratio 1.38 1.45 1.22 1.29 1.23 1.59 1.39 1.12 1.04 0.83 2.28 Quick Ratio 1.06 1.12 0.87 0.91 0.88 1.21 1.09 0.76 0.69 0.54 2.15 Debt/Equity 2.47 2.1 1.47 0.99 0.74 0.85 1.29 2.74 3.04 4.82 0.55